Pharmacological regulation of TRPM7 can benefit patients with immune and cardiovascular disorders, tissue fibrosis and tumours3,11–13 and several small-molecule TRPM7 inhibitors and activators have been already examined preclinically40,41. Here, TRPM7 is linked to cardiovascular disorder.